Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2023-04-07 00:00:00 ET · period of report 2023-04-06 · accession 0001209191-23-023749 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-07 | 2023-04-06 | PHAT | Henderson Molly | CFO, CBO | S - Sale | $7.27 | -3,439 | 72.6K | -5% | -$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-06 | S | D | 3,439 | $7.27 | 72,576 | D | — | — | (F2) Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units. |